Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveM&A18 Aug 2026

Alivus Life Sciences Ltd

Enclosed please find herewith intimation pursuant to Regulation 30 of SEBI (LODR), 2015 with respect to acquisition.

Alivus Life Sciences Ltd has announced the acquisition of 76% stake in IQGEN-X Pharma Private Limited for INR 9.12 crores, subject to customary adjustments. The acquisition is expected to provide a wider spectrum for the company to offer a complete end-to-end solution to its customers in both API and CDMO space.

Read more →📎 1 attachment
NSEAcquisitionM&A18 Aug 2026

EFC (I) Limited

Acquisition

EFC (I) Limited has informed the Exchange about the acquisition of Ultrafresh Modular Solutions Limited, a 51% subsidiary of TTK Prestige Limited, for 100% of its issued and paid-up capital on a fully-diluted basis.

Read more →📎 1 attachment
BSECompany UpdateM&A18 Aug 2026

EFC (I) Ltd

As per the attached Intimation.

EFC (I) Ltd has announced the acquisition of Ultrafresh Modular Solutions Limited, a 51% subsidiary of TTK Prestige Limited, through a share swap mechanism. The acquisition aims to strengthen and further scale the Company's existing furniture manufacturing and Design & Built solutions business. The transaction has been done at arm's length, and the acquisition is expected to create operational and business synergies, broaden the Company's product offerings, and enhance manufacturing and distribution capabilities.

Read more →📎 1 attachment
NSEOutcome of Board MeetingM&A18 Aug 2026

EFC (I) Limited

Outcome of Board Meeting

EFC (I) Limited has informed the Exchange regarding Outcome of Board Meeting held on August 18, 2026. The Board considered and approved the acquisition of 100% stake in Ultrafresh Modular Solutions Limited, issuance of up to 19,99,996 equity shares to the sellers, and conducting a Postal Ballot for seeking the approval of the shareholders for the proposed preferential issue of equity shares.

Read more →📎 1 attachment
BSEBoard MeetingM&A18 Aug 2026

EFC (I) Ltd

Outcome of Board Meeting is attached.

EFC (I) Ltd has announced the acquisition of 100% stake in Ultrafresh Modular Solutions Ltd, a modular home solutions provider, for a consideration of Rs. 270 per equity share. The company will issue up to 19,99,996 equity shares to the sellers on a preferential basis, subject to shareholder and regulatory approvals.

Read more →📎 1 attachment
NSEGeneral UpdatesM&A18 Aug 2026

RHI MAGNESITA INDIA LIMITED

General Updates

RHI Magnesita India Limited has completed the merger of its wholly owned subsidiary, Intermetal Engineers (India) Private Limited, with Ashwath Technologies Private Limited. The Appointed Date of the Scheme is 1 April 2026. The Scheme is expected to result in operational efficiencies, rationalisation of the corporate structure, and administrative synergies, yielding benefits for the companies and their stakeholders.

Read more →📎 1 attachment
BSECompany UpdateM&A18 Aug 2026

Rhi Magnesita India Ltd

Intermetal wholly owned subsidiary company of RHI Magnesita India Limited has received letter today 18 August 2026

Rhi Magnesita India Ltd's wholly owned subsidiary Intermetal Engineers (India) Private Limited has completed its merger with Ashwath Technologies Private Limited, a wholly owned subsidiary of Intermetal, effective from 1 April 2026. The merger is expected to result in operational efficiencies and administrative synergies, yielding benefits for the companies and their stakeholders.

Read more →📎 1 attachment
BSECompany UpdateM&A18 Aug 2026

Jai Mata Glass Ltd

Recommendation on open offer to the Shareholders of Jai Mata Glass Ltd by committee of Independent Director

Jai Mata Glass Ltd has received recommendations from a committee of independent directors for an open offer to its shareholders by Mr. Ashwani Gulati, Ms. Kiran Gulati, and M/s Veerasha Trust. The open offer is to acquire up to 2,60,00,000 equity shares, representing 26% of the company's paid-up equity share capital, at a price of INR 1.85 per share.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A18 Aug 2026

Infosys Ltd

Enclosed

Infosys Ltd has collaborated with Knorr-Bremse AG to accelerate AI-enabled enterprise transformation. The collaboration will help Knorr-Bremse AG simplify and modernize its IT landscape, improve service quality, and accelerate its shift toward a value-driven, future-ready IT operating model.

Read more →📎 1 attachment
NSEUpdates▲ PositiveM&A18 Aug 2026

Infosys Limited

Updates

Infosys Limited has announced a strategic collaboration with Knorr-Bremse AG to accelerate AI-enabled enterprise transformation. The collaboration will help Knorr-Bremse simplify and modernize its IT landscape, improve service quality, and accelerate its shift toward a value-driven, future-ready IT operating model.

Read more →📎 1 attachment
BSECompany UpdateM&A18 Aug 2026

Markolines Pavement Technologies Ltd

Markolines Pavement Technologies Limited informed the esteemed exchange regarding receipt of observation letters with no adverse objection from BSE Limited and National Stock Exchange of ....

Markolines Pavement Technologies Ltd has received observation letters with no adverse objection from BSE Limited and National Stock Exchange of India Limited on the proposed Scheme of Amalgamation between Markolines Infra Limited and Markolines Pavement Technologies Limited.

Read more →📎 1 attachment
NSEAmalgamation/MergerM&A18 Aug 2026

Markolines Pavement Technologies Limited

Amalgamation/Merger

Markolines Pavement Technologies Limited has informed the Exchange about receipt of observation letter with no adverse objection from BSE Limited and NSE Limited regarding the Scheme of Amalgamation between Markolines Infra Limited and Markolines Pavement Technologies Limited.

Read more →📎 1 attachment
NSEAcquisition▲ PositiveM&A18 Aug 2026

Piramal Pharma Limited

Acquisition

Piramal Pharma Limited has acquired an additional 40.67% stake in Yapan Bio Private Limited, increasing its shareholding from 33.33% to 74.00%. The acquisition was completed for an aggregate cash consideration of approximately ₹76 crores. Yapan has ceased to be an associate company and has become a subsidiary of Piramal Pharma Limited.

Read more →📎 1 attachment
← PreviousPage 113 of 182Next →